Objective
To describe the epidemiology of noninvasive ventilation (NIV) therapy for patients admitted to pediatric cardiac intensive care units (CICU), and to assess practice variation across hospitals.
Design
Retrospective cohort study using prospectively collected clinical registry data.
Setting
Pediatric Cardiac Critical Care Consortium (PC4) clinical registry.
Patients
Patients admitted to CICUs at PC4 hospitals.
Interventions
None.
Measurements and Main Results
We analyzed all CICU encounters that included any respiratory support from 10/2013-12/2015. NIV therapy included high flow nasal cannula (HFNC) and positive airway pressure (PAP) support. We compared patient and, when relevant, perioperative characteristics of those receiving NIV to all others. Subgroup analysis was performed on neonates and infants undergoing major cardiovascular surgery. To examine duration of respiratory support we created a casemix-adjustment model and calculated adjusted mean durations of total respiratory support (MV + NIV), MV, and NIV. We compared adjusted duration of support across hospitals. The cohort included 8,940 encounters from 15 hospitals: 3,950 (44%) received NIV, 72% were neonates and infants. Medical encounters were more likely to include NIV than surgical. In surgical neonates and infants, 2,032 (55%) received postoperative NIV. Neonates, extracardiac anomalies, single ventricle, procedure complexity, preoperative respiratory support, MV duration, and postoperative disease severity were associated with NIV therapy (p<0.001 for all). Across hospitals, NIV use ranged from 32%-65%, and adjusted mean NIV duration ranged from 1-4 days (3 days observed mean). Duration of total adjusted respiratory support was more strongly correlated with duration of MV compared to NIV (Pearson's r=0.93 vs 0.71, respectively).
Conclusions
NIV use is common in CICUs, especially in patients admitted for medical conditions, infants, and those undergoing high complexity surgery. We observed wide variation in NIV use across hospitals, though the primary driver of total respiratory support time seems to be duration of MV.